Order Article Reprints

García-Serran A, Ordoño J, DeGregorio-Rocasolano N, Melià-Sorolla M, Odendaal K, Martí-Sistac O, Gasull T. Targeting Pro-Oxidant Iron with Exogenously Administered Apotransferrin Provides Benefits Associated with Changes in Crucial Cellular Iron Gate Protein TfR in a Model of Intracerebral Hemorrhagic Stroke in Mice. Antioxidants. 2023; 12(11):1945. https://doi.org/10.3390/antiox12111945

García-Serran, Alexia, Jesús Ordoño, Núria DeGregorio-Rocasolano, Marc Melià-Sorolla, Karla Odendaal, Octavi Martí-Sistac, and Teresa Gasull. 2023. "Targeting Pro-Oxidant Iron with Exogenously Administered Apotransferrin Provides Benefits Associated with Changes in Crucial Cellular Iron Gate Protein TfR in a Model of Intracerebral Hemorrhagic Stroke in Mice" Antioxidants 12, no. 11: 1945. https://doi.org/10.3390/antiox12111945

García-Serran, A., Ordoño, J., DeGregorio-Rocasolano, N., Melià-Sorolla, M., Odendaal, K., Martí-Sistac, O., & Gasull, T. (2023). Targeting Pro-Oxidant Iron with Exogenously Administered Apotransferrin Provides Benefits Associated with Changes in Crucial Cellular Iron Gate Protein TfR in a Model of Intracerebral Hemorrhagic Stroke in Mice. Antioxidants, 12(11), 1945. https://doi.org/10.3390/antiox12111945